Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,291 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neoechinulin a imparts resistance to acute nitrosative stress in PC12 cells: a potential link of an elevated cellular reserve capacity for pyridine nucleotide redox turnover with cytoprotection.
Akashi S, Shirai K, Okada T, Konishi K, Takeuchi T, Kuramochi K, Takahashi M, Nakagawa T, Ogura Y, Fujieda S, Shibata Y, Sugawara F, Kobayashi S, Watanabe N, Arai T. Akashi S, et al. Among authors: nakagawa t. Biol Pharm Bull. 2012;35(7):1105-17. doi: 10.1248/bpb.b12-00055. Biol Pharm Bull. 2012. PMID: 22791159 Free article.
Novel therapeutic strategies targeting bypass pathways and mitochondrial dysfunction to combat resistance to RET inhibitors in NSCLC.
Shiba-Ishii A, Isagawa T, Shiozawa T, Mato N, Nakagawa T, Takada Y, Hirai K, Hong J, Saitoh A, Takeda N, Niki T, Murakami Y, Matsubara D. Shiba-Ishii A, et al. Among authors: nakagawa t. Biochim Biophys Acta Mol Basis Dis. 2024 May 18:167249. doi: 10.1016/j.bbadis.2024.167249. Online ahead of print. Biochim Biophys Acta Mol Basis Dis. 2024. PMID: 38768929
Correction: Effectiveness and safety of weekly paclitaxel and cetuximab as a salvage chemotherapy following immune checkpoint inhibitors for recurrent or metastatic head and neck squamous cell carcinoma: a multicenter clinical study.
WakasakiI T, Manako T, YasumatsuI R, Hara H, Toh S, Masuda M, YamauchiID M, Kuratomi Y, Nishimura E, Takeuchi T, Matsuo M, Jiromaru R, Hashimoto K, Komune N, Nakagawa T. WakasakiI T, et al. Among authors: nakagawa t. PLoS One. 2024 May 9;19(5):e0303720. doi: 10.1371/journal.pone.0303720. eCollection 2024. PLoS One. 2024. PMID: 38722895 Free PMC article.
Efficacy and safety of biosimilar infliximab in bio-naïve patients with Crohn's disease.
Oike T, Akizue N, Ohta Y, Koseki H, Saito M, Yokoyama Y, Imai Y, Taida T, Okimoto K, Saito K, Ogasawara S, Matsumura T, Nakagawa T, Arai M, Katsuno T, Fukuda Y, Kitsukawa Y, Kato J, Kato N. Oike T, et al. Among authors: nakagawa t. Arab J Gastroenterol. 2024 May 6:S1687-1979(24)00036-4. doi: 10.1016/j.ajg.2024.03.006. Online ahead of print. Arab J Gastroenterol. 2024. PMID: 38714472
5,291 results